BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20676125)

  • 21. PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL.
    Cubedo E; Maurin M; Jiang X; Lossos IS; Wright KL
    FEBS J; 2011 Sep; 278(17):3065-75. PubMed ID: 21722313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.
    Larson RC; Lavenir I; Larson TA; Baer R; Warren AJ; Wadman I; Nottage K; Rabbitts TH
    EMBO J; 1996 Mar; 15(5):1021-7. PubMed ID: 8605871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
    Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
    Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.
    Oram SH; Thoms J; Sive JI; Calero-Nieto FJ; Kinston SJ; Schütte J; Knezevic K; Lock RB; Pimanda JE; Göttgens B
    Leukemia; 2013 Jun; 27(6):1348-57. PubMed ID: 23302769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
    McCormack MP; Forster A; Drynan L; Pannell R; Rabbitts TH
    Mol Cell Biol; 2003 Dec; 23(24):9003-13. PubMed ID: 14645513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2.
    Wang Q; Zhang M; Wang X; Yuan W; Chen D; Royer-Pokora B; Zhu T
    Leukemia; 2007 May; 21(5):1015-25. PubMed ID: 17361224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
    Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; van Grotel M; Beverloo HB; Lee C; Helgason T; Buijs-Gladdines J; Passier M; van Wering ER; Veerman AJ; Kamps WA; Meijerink JP; Pieters R
    Blood; 2006 Nov; 108(10):3520-9. PubMed ID: 16873670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of genes potentially involved in LMO2-induced leukemogenesis.
    Davenport J; Neale GA; Goorha R
    Leukemia; 2000 Nov; 14(11):1986-96. PubMed ID: 11069036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
    Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
    Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
    Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
    Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
    Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
    Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
    de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
    Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL.
    Dik WA; Nadel B; Przybylski GK; Asnafi V; Grabarczyk P; Navarro JM; Verhaaf B; Schmidt CA; Macintyre EA; van Dongen JJ; Langerak AW
    Blood; 2007 Jul; 110(1):388-92. PubMed ID: 17360939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.
    Bonadies N; Göttgens B; Calero-Nieto FJ
    PLoS One; 2015; 10(7):e0131577. PubMed ID: 26161748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.
    Drynan LF; Hamilton TL; Rabbitts TH
    Oncogene; 2001 Jul; 20(32):4412-5. PubMed ID: 11466623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Of mice and men: how an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia.
    Hoang T
    Sci Transl Med; 2010 Mar; 2(21):21ps10. PubMed ID: 20374994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.